1887

Abstract

A combination of phage peptide display library mapping and pepscanning, with both murine monoclonal antibodies and a panel of well-characterized human sera, have been used in order to define type-specific epitopes of glycoprotein G of herpes simplex virus type 2 (HSV-2) (gG2). Both techniques revealed an immunodominant region of gG2, centred around amino acids 525-587 of the uncleaved gG2 molecule. A soluble peptide, equivalent to amino acids 551-570, when used as antigen in an ELISA format was recognized by three out of five murine MAbs and by 20/26 (77%) Western blot anti-HSV-2-positive human sera, but by only 1/63 Western blot anti-HSV-2-negative sera (specificity, 98%). The sensitivity of detection of human anti-HSV-2 antibodies was increased to 90% using a peptide derived from this region, presented on a nitrocellulose membrane. This highly antigenic and type-specific domain of gG2 is located at the junction between the ‘unique’ region of gG2 and its C-terminal end, which has approximately 50% identity with gG1. A second antigenic region of gG2, amino acids 351-427, which lies within the ‘unique’ part of gG2, was also identified by both techniques employed in this study and is recognized by a proportion of anti-HSV-2-positive sera. These findings demonstrate the feasibility of developing a peptide-based type-specific assay for the detection of anti-HSV-2 antibody in human sera based on type-specific epitopes of gG2 and have implications for the understanding of the three-dimensional topography of gG2.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-7-1789
1999-07-01
2022-05-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/7/0801789a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-7-1789&mimeType=html&fmt=ahah

References

  1. Ashley R. L., Wu L., Pickering J. W., Tu M.-C., Schnorenberg L. 1998; Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. Journal of Clinical Microbiology 36:294–295
    [Google Scholar]
  2. Corey L., Adams H. G., Brown Z. A., Holmes K. K. 1983; Genital herpes simplex virus infections: clinical manifestations, course and complications. Annals of Internal Medicine 98:958–972
    [Google Scholar]
  3. Dolter K. E., Goins W. F., Levine M., Glorioso J. C. 1992; Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. Journal of Virology 66:4864–4873
    [Google Scholar]
  4. Geysen H. M., Meloen R. H., Barteling S. J. 1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proceedings of the National Academy of Sciences, USA 81:3998–4002
    [Google Scholar]
  5. Geysen H. M., Rodda S. J., Mason T. M. 1996; The delineation of peptides able to mimic assembled epitopes. In Synthetic Peptides as Antigens vol 119 pp 131–149 Edited by Porter R., Wheeler J. New York: John Wiley;
    [Google Scholar]
  6. Gibbs R. S., Mead P. B. 1992; Preventing neonatal herpes – current strategies. New England Journal of Medicine 326:946–947
    [Google Scholar]
  7. Grabowska A., Irving W. L. 1996; Epitope mapping using phage peptide display libraries: implications for diagnosis and vaccine development. Public Health Laboratory Services Microbiology Digest 13:132–137
    [Google Scholar]
  8. Ho D. W. T., Field P. R., Sjogren-Jansson E., Jeansson S., Cunningham A. L. 1992; Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG2). Journal of Virological Methods 36:249–264
    [Google Scholar]
  9. Ho D. W. T., Field P. R., Irving W. L., Packham D. R., Cunningham A. L. 1993; Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blotting (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. Journal of Clinical Microbiology 31:3157–3164
    [Google Scholar]
  10. Koutsky L. A., Stevens C. E., Holmes K. K., Ashley R. L., Kiviat N. B., Critchlow C. W., Corey L. 1992; Underdiag nosis of genital herpes by current clinical and viral-isolation procedures. New England Journal of Medicine 326:1533–1539
    [Google Scholar]
  11. Kulhanjian J. A., Sourosh V., Au D. S., Bronzan N., Yasukawa L. E., Weylman L. E., Arvin A. M., Prober C. G. 1992; Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. New England Journal of Medicine 326:916–920
    [Google Scholar]
  12. Lee F. K., Coleman R. M., Pereira L., Bailey P. D., Tatsuno M., Nahmias A. J. 1985; Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. Journal of Clinical Microbiology 22:641–644
    [Google Scholar]
  13. Levi M., Ruden U., Wahren B. 1996; Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clinical and Diagnostic Laboratory Immunology 3:265–269
    [Google Scholar]
  14. Liljeqvist J.-Å., Trybala E., Svennerholm B., Jeansson S., Sjogren-Jansson E., Bergstrom T. 1998; Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. Journal of General Virology 79:1215–1224
    [Google Scholar]
  15. McGeoch D. J., Moss H. W. M., McNab D., Frame M. C. 1987; DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. Journal of General Virology 68:19–38
    [Google Scholar]
  16. McKenzie R., Straus S. E. 1996; Vaccine therapy for herpes simplex virus infections: an historical perspective. Reviews in Medical Virology 6:85–96
    [Google Scholar]
  17. Marsden H. S., MacAulay K., Murray J., Smith I. W. 1998; Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. Journal of Medical Virology 56:79–84
    [Google Scholar]
  18. Motti C., Nuzzo M., Meola A., Galfre G., Felici F., Cortese R., Nicosia A., Monaci P. 1994; Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 146:191–198
    [Google Scholar]
  19. Smith G. P. 1993; Surface display and peptide libraries. Gene 128:1–2
    [Google Scholar]
  20. Smith G. P., Scott J. K. 1993; Libraries of peptides and proteins displayed on filamentous phage. Methods in Enzymology 217:228–257
    [Google Scholar]
  21. Stanberry L. R. 1995; Herpes simplex virus vaccines as immuno-therapeutic agents. Trends in Microbiology 3:244–247
    [Google Scholar]
  22. Van Regenmortel M. H. V. 1989; Structural and functional approaches to the study of protein antigenicity. Immunology Today 10:266–272
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-7-1789
Loading
/content/journal/jgv/10.1099/0022-1317-80-7-1789
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error